INTRODUCTION
Like most other membrane glycoproteins of both viral and cellular origin, herpes simplex virus type 1 (HSV-l) glycoproteins contain N-glycosyl oligosaccharides (Hope & Marsden, 1983; Pizer et al., 1980; Serafini-Cessi & Campadelli-Fiume, 1981 ; Wenske et al., 1982) . In addition to these carbohydrates, one of the HSV-l-specified glycoproteins, designated gC-1, also contains O-glycosyl oligosaccharides with affinity for the N-acetylgalactosamine (GalNAc)-binding Helixpomatia lectin (HPA) (Olofsson et al., 1981 (Olofsson et al., , 1983a . This lectin has been reported to bind to a restricted number of surface carbohydrates only, including biologically active structures such as blood group A substance, the Forssman antigen and some differentiation antigens glycoprotein in nature (Gahmberg & Andersson, 1982; Goldstein & Hayes, 1978; Hammarstr6m et al., 1973) . Although other HSV-1 glycoproteins contain O-linked oligosaccharides (Johnson & Spear, 1983) , the HPA-binding activity is associated largely, if not exclusively, with gC-1 (Olofsson et al., 1981 (Olofsson et al., , 1983b . The HPA-binding activity appears thus to be a factor distinguishing gC-1 from other HSV glycoproteins. HSV-2. Thus, the antiserum precipitated 30 to 40 % of the lectin-purified glycoprotein, while the preimmune serum precipitated no activity above the background level (0"4~o).
Characterization of the HPA-binding HSV-2-specific glycoprotein
As the HPA-binding activity of HSV-l-infected cells is associated mainly, if not exclusively, with gC-1 (Olofsson et al., 1981 (Olofsson et al., , 1983 it seemed likely that the HPA-binding HSV-2-specified glycoprotein could be related to gC-2. To identify gC-2 we used a rabbit antiserum (K642) obtained after immunization with gC-1, purified by affinity chromatography with gC-1-specific monoclonal antibody (Olofsson et al., 1983a) . This antibody precipitated two HSV-2 polypeptides migrating in the 70K to 80K region (Fig. 2e ).
Owing to their molecular weight and reactivity with a polyclonal, exclusively gC-specific antiserum, we concluded that these polypeptides were related to or identical with gC-2, recently characterized and defined by Zezulak & Spear (1983) and Zweig et al. (1983) . No HSV-2-specified glycoprotein in the 130K region was precipitated by antiserum K642 (Fig. 2e) . It was also found that this antiserum precipitated less than 1% of the eluted fraction from the HPAbinding fraction of [3H]glucosamine-labelled extracts from HSV-2-infected cells. In conclusion, the data indicated that the HPA-binding glycoprotein was distinct from gC-2.
Genetic mapping of the HSV-2-specified HPA-binding glycoprotein
An HSV-2 type-specific monoclonal antibody prepared from mice immunized with purified HPA-binding glycoprotein was used as a probe in the mapping studies. This monoclonal antibody (designated O 1 C5) precipitated one single [3H]glucosamine-labelled polypeptide with a slightly higher apparent molecular weight (about 130K) than the HPA-binding glycoprotein fraction from HSV-2-infected cells (Fig. 3) . A similar phenomenon has been observed for gC-1, in as much as the H P A -b i n d i n g fraction of gC-1 has a higher mobility that the n o n -b i n d i n g fraction probably caused by the differences in carbohydrate composition (Olofsson et al., 1983b) . However, more than 8 5~ of the eluted H P A -b i n d i n g fractions from the chromatography shown in Fig. 1 was precipitated by this antibody, confirming that the H P A -b i n d i n g glycoprotein was recognized by the antibody.
In the m a p p i n g study, [3H]glucosamine-labelled extracts from G M K cells infected with the intertypic recombinants were subjected to radioimmunoprecipitation with O 1 C5. The genomic structures of these recombinants are shown in Fig. 4 . The a m o u n t of radioactivity precipitated is shown in Table 1 , expressed as a percentage of the total radiolabel added to the reaction mixture. Control experiments with extracts from uninfected cells showed that the background was 0.7 + 0.1 ~ (M + S.E.M., n = 5). All results less t h a n 1.5% (2 x background) were scored as negative. Using this background limit, clearcut results were obtained with all recombinants, indicating a m a p p i n g position delimited on the left by r e c o m b i n a n t R D I 0 4 and on the right by R12-1 (0.892 Glucosamine-labelled extracts from GMK cells infected with the intertypic recombinants indicated were subjected to radioimmunoprecipitation with monoclonal antibodies against HSV-2-specified HPA-binding glycoprotein (O1 C5).
to 0.924). These data are compatible with those obtained by Marsden et al. (1982 Marsden et al. ( , 1984 for the HSV-2-induced glycoprotein g92K.
Finally, the HPA-binding glycoprotein from HSV-2-infected cells was subjected to radioimmunoprecipitation with monoclonal antibody AP 1, which was used as a probe for g92K by Marsden et al. (1984) and monoclonal antibody 1206-3 used for characterization of gG-2 by Roizman et al. (1984) . Both antibodies precipitated 85~ of the HPA-binding HSV-2-specified glycoprotein. When tested in the ELISA system, described by Svennerholm et al. (1984) both monoclonal antibodies demonstrated titres higher than 100000 against the HPA-binding glycoprotein from HSV-2-infected cells and less than 50 against the corresponding antigen from HSV-1-infected cells. The mapping data and the similar antigenic reactivity therefore indicated that the HPA-binding HSV-2-specified glycoprotein was identical with g92K and gG-2. DISCUSSION This paper shows that only one of the HSV-2-specified glycoproteins has affinity for the GalNAc-binding lectins HPA and SBA. Similar lectin affinities were reported previously for gC but for no other HSV-l-specified glycoprotein (Olofsson et al., 1981 (Olofsson et al., , 1983 . Judging from these unique lectin-binding properties it seemed reasonable to assume that the HSV-2-specified HPAbinding glycoprotein was related to or identical with gC-2. However, our data from the radioimmunoprecipitation analysis and subsequent SDS PAGE were not compatible with this assumption. Furthermore, the mapping position of the HPA-binding HSV-2-specified glyeoprotein (as discussed in some detail below) was found to be in the S component, situated at least 0.2 map units from the map position of gC-2, delimited by 0.62 and 0.64 map units (Zezulak & Spear, 1984) . In conclusion, both immunological and mapping data indicate that gC-2 and the HPA-binding glycoproteins are two distinct HSV-2-specified glycoprotein species.
The mapping studies in the present report were performed with the same HSV-1 × HSV-2 intertypic recombinants as used by Marsden et aL (1984) for the characterization of a HSV-2-specific glycoprotein, designated g92K. Previous studies using 18 HSV-1 × HSV-2 intertypic recombinants concordantly gave a genomic location for g92K between coordinates 0.846 and 0.924 (Marsden et al., , 1984 . However, two of them R12-3 and RD104 gave mutually incompatible locations. More recently, the genome structures of a number of the recombinants have been investigated in more detail. These studies (A. C. Minson, personal communication) revealed that the stock of R12-3 appeared to be a mixture of two populations and contained previously undetected HSV-2 sequences in Us. Consequently, R12-3 cannot be used for mapping purposes. The effect of omitting the data for R12-3 on our previously published map position for g92K is to narrow the location further, to between coordinates 0.892 and 0.924, delimited on the left by RD 104 at the HSV-2 BglIl q-1 site and on the right by R 12-I at the HSV-2 BamHI c'-d' site. The results indicated similar mapping positions for g92K and the HPAbinding glycoprotein in the S component delimited by map coordinates 0.892 and 0.924 (Marsden et al., 1984) . Of particular significance was the observation that recombinant R12-1 did not induce the HPA-binding HSV-2 glycoprotein (Table 1 ) since this recombinant has been shown (Marsden et al., 1984) to induce gE-2 and a gD with mobility distinct from that induced by HSV-1 or HSV-2. Taken together, these results suggest that like g92K the HPA-binding HSV-2 glycoprotein is encoded by a region in the S component at least in part different from that coding for gD and gE. In conclusion, the mapping data and the finding that the HPA-binding glycoprotein was almost quantitatively precipitated by the g92K-specific monoclonal antibody AP1 indicate that g92K and the HPA-binding HSV-2-specified glycoprotein are identical. The different apparent molecular weight (130K) reported in this paper is due to different electrophoretic systems used in the present study and in that of Marsden et al. (1984) .
Recently, an HSV-2-specified glycoprotein, designated gG, was identified as a fully glycosylated polypeptide (i) with apparent tool. wt. of 124K to 136K, (ii) mapping in the S component and (iii) reacting with an HSV-2-specific monoclonal antibody, designated H 966 or 1206-3 (Roizman et al., 1984) . The HPA-binding HSV-2-specified glycoprotein fulfils all these criteria. Further similarities between gG-2 and the HPA-binding glycoprotein is a dominant type-specific immunological reactivity (Roizman et al., 1984; Svennerholm et al., 1984) and that no HSV-1-specified counterpart mapping in the same region has been identified. Consequently, our data indicate that the HPA-binding glycoprotein in the present study and gG-2 in fact are one and the same glycoprotein.
Affinity for GalNAc-specific lectins is a phenotypic property of gC-1 and gG-2 but no other HSV glycoproteins including gC-2. One intriguing question is whether or not this property also reflects similarities in the amino acid sequences between these two glycoproteins. In other words, which is the mechanism selecting only these two glycoproteins for addition of HPAbinding carbohydrates? One of three explanations seems plausible. (i) The genes encoding gC-1 and gG-2 belong to the same transcriptional class, permitting peak biosynthesis of both glycoproteins at a selected period of time when the necessary glycosyl transferases are active. (ii) Both glycoproteins contain signals for transport to special compartments of the cells where the necessary glycosyl transferases are expressed. The existence of such peptide signals directing viral glycoproteins to subcellular locations has been postulated for other viruses (RodriguezBoulan & Sabatini, 1978; Morrison & Ward, 1984) . (iii) The addition of HPA-binding oligosaccharides requires special attachment sequences only present in gC-1 and gG-2. The peptide signal requirements for addition of N-glycosyl oligosaccharides are known in detail (Ronin et al., 1978) , but very little is known about such structural factors governing the attachment of O-glycosyl oligosaccharides (Kessler et al., 1979; Takayashu et al., 1982) . As HSV glycoproteins other than gC-1 and gG-2 contain O-linked carbohydrates (Johnson & Spear, 1983) , this explanation would imply that the peptide structure also might influence terminal properties of O-linked oligosaccharides.
Explanations (ii) and (iii) strongly implicate similarities in at least some part of the amino acid sequences of gC-1 and gG-2. Such similarities have not been detected immunologically (Zezulak & Spear, 1983; Roizman et al., 1984; Marsden et al., 1984) but they may be masked by the large HPA-binding carbohydrates (Olofsson et al., ~983a) . Any special peptide sequence in gC-1 responsible for the addition of HPA-binding oligosaccharides should be absent or aberrant in gC-2. It is therefore interesting that although there is a high degree of homology between the amino acid sequences of gC-1 and gC-2 it was shown by two laboratories that gC-1 contains a 27 amino acid sequence, near the amino terminus, which appears to be totally lacking in the gC-2 sequence (Dowbenko & Lasky, 1984; Swain et al., 1985) . It was suggested that there is a more pronounced evolutionary divergence between gC-1 and gC-2 than between other HSV-1 glycoproteins such as gB-1, gD-1 and gE-1, and their HSV-2-specified counterparts (Zezulak & Spear, 1983) . The results of the present paper seem to be another example of this divergence.
